BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1918319)

  • 1. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma.
    Sethna MP; Lampson LA
    J Neuroimmunol; 1991 Nov; 34(2-3):121-32. PubMed ID: 1918319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation and induction of major histocompatibility complex class I and II antigens on microglial cells in early postnatal rat brain following intraperitoneal injections of recombinant interferon-gamma.
    Xu J; Ling EA
    Neuroscience; 1994 Jun; 60(4):959-67. PubMed ID: 7936214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and temporal regulation of the immune response in the rat brain to intracerebroventricular injection of interferon-gamma.
    Peng ZC; Kristensson K; Bentivoglio M
    Exp Neurol; 1998 Dec; 154(2):403-17. PubMed ID: 9878178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
    Akbasak A; Oldfield EH; Saris SC
    J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma.
    Phillips LM; Lampson LA
    J Neuroimmunol; 1999 May; 96(2):218-27. PubMed ID: 10337920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-specific variation in constitutive and inducible expression of MHC class II, class I and ICAM-1 on rat cerebral endothelium.
    Linke AT; Male DK
    Immunology; 1994 May; 82(1):88-94. PubMed ID: 7913916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II antigens on retinal vascular endothelium, pericytes, macrophages, and lymphocytes of the rat.
    Fujikawa LS; Reay C; Morin ME
    Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):66-73. PubMed ID: 2783579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformed by v-Ki-ras.
    Morris AG; Ward GA; Bateman WJ
    Br J Cancer; 1989 Aug; 60(2):211-5. PubMed ID: 2504267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different microvascular endothelial cell phenotypes exhibit different class I and II antigens under interferon-gamma.
    Spanel-Borowski K; Bein G
    In Vitro Cell Dev Biol Anim; 1993 Aug; 29A(8):601-2. PubMed ID: 8376306
    [No Abstract]   [Full Text] [Related]  

  • 13. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
    Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
    Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
    Doukas J; Pober JS
    J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines stimulate the IFN-gamma-induced class II MHC expression on bovine brain capillary endothelial cells.
    Coutinho GC; Durieu-Trautmann O; Strosberg AD; Couraud PO
    J Immunol; 1991 Oct; 147(8):2525-9. PubMed ID: 1717565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system.
    Vass K; Lassmann H
    Am J Pathol; 1990 Oct; 137(4):789-800. PubMed ID: 2121041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma induction of major histocompatibility complex antigens on cultured bovine luteal cells.
    Fairchild DL; Pate JL
    Biol Reprod; 1989 Mar; 40(3):453-7. PubMed ID: 2503068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats.
    Pedersen EB; McNulty JA; Castro AJ; Fox LM; Zimmer J; Finsen B
    J Neuroimmunol; 1997 Jun; 76(1-2):117-31. PubMed ID: 9184641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha.
    Turnley AM; Miller JF; Bartlett PF
    Neurosci Lett; 1991 Feb; 123(1):45-8. PubMed ID: 1712090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 (ICAM-1) on renal cell cancer. De novo expression and modulation by cytokines on renal cell cancer cell lines].
    Tomita Y; Nishiyama T; Sato S; Fujiwara M
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):232-8. PubMed ID: 1674973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.